ASHP Survey of Health-System Specialty Pharmacy Practice: Practice Models, Operations, and Workforce-2022

被引:2
作者
Kelley, Tara N. [1 ]
Canfield, Scott [2 ]
Diamantides, Erica [3 ]
Ryther, Ashley M. K. [4 ]
Pedersen, Craig A. [5 ,6 ]
Pierce, Gabrielle [7 ]
机构
[1] Vanderbilt Specialty Pharm Serv, Nashville, TN 37232 USA
[2] Johns Hopkins Home Care Grp, Clin Program Dev, Baltimore, MD USA
[3] Tufts Med, Specialty Pharm Serv, Boston, MA USA
[4] Univ Utah Hlth, Salt Lake City, UT USA
[5] Virginia Mason Franciscan Hlth, Seattle, WA USA
[6] Univ Washington, Seattle, WA USA
[7] Amer Soc Hlth Syst Pharmacists, Sect Specialty Pharm Practitioners, Bethesda, MD USA
关键词
healthcare quality; integrated delivery of healthcare; pharmacy practice model; specialty medication; specialty pharmacy; survey; CARE; SERVICES; IMPLEMENTATION; PROGRAM; ACCESS;
D O I
10.1093/ajhp/zxad235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: The results of the 2022 American Society of Health-System Pharmacists (ASHP) Survey of Health-System Specialty Pharmacy (HSSP) Practice: Practice Models, Operations, and Workforce are presented.Methods: A total of 273 leaders in HSSPs were contacted by email to complete a survey hosted using Qualtrics. The survey sample was compiled from ASHP member lists, the presence of a specialty pharmacy indicated in previous ASHP surveys, and outreach to ASHP member organizational leaders.Results: The survey response rate was 35.9%. Most HSSPs dispense 30,000 or fewer specialty prescriptions annually. Most respondents have an annual revenue of $100 million or less, are part of a 340B-covered entity, operate one location, have 1 to 2 specialty pharmacy accreditations, dispense both nonspecialty and specialty medications, and employ an average of 15.5 pharmacists and 17.6 technicians. The majority (66.7%) dispense 50% or less of prescriptions written by internal providers due to payor and manufacturer network restrictions. Over one-third employ nonpharmacist and nontechnician professionals. Specialty pharmacists are involved in treatment decisions and therapy selection before prescription generation (69.8%), and 47.7% of respondents report pharmacists operating under collaborative practice agreements. Most (82.6%) offer experiential or formal education in specialty pharmacy. The top point of pride remains patient satisfaction and level of service. Top challenges include access to payor networks, the ability to hire and retain qualified staff, and shrinking reimbursement from payors.Conclusion: The HSSP is a continually maturing integrated advanced practice model focused on providing patient-centric care to all patients and employees of the health system regardless of network status. HSSPs are raising the standards for quality in specialty pharmacy care.
引用
收藏
页码:1796 / 1821
页数:26
相关论文
共 27 条
  • [1] American Society of Health-System Pharmacists, OUTC LIT LIB
  • [2] Comparison of provider satisfaction with specialty pharmacy services in integrated health-system and external practice models: A multisite survey
    Anguiano, Rebekah H.
    Zuckerman, Autumn D.
    Hall, Elizabeth
    Diamantides, Erica
    Kumor, Lisa
    Duckworth, Deborah L.
    Peter, Megan
    Sorgen, Patrick J.
    Nathanson, Amy
    Kandah, Huda-Marie
    Dura, Jillian
    Campbell, Udobi
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (11) : 962 - 971
  • [3] Bagwell A, 2017, J MANAG CARE SPEC PH, V23, P815, DOI 10.18553/jmcp.2017.23.8.815
  • [4] Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy
    Berger, Nate
    Peter, Megan
    DeClercq, Josh
    Choi, Leena
    Zuckerman, Autumn D.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (12) : E380 - E387
  • [5] Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system
    Brouwer, Elizabeth
    Yeung, Kai
    Barthold, Douglas
    Hansen, Ryan
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (06) : 732 - 742
  • [6] Hepatitis C virus infection and the role of a pharmaceutical care program
    Chamorro-de-Vega, E.
    Rodriguez-Gonzalez, C. G.
    Gimenez-Manzorro, Alvaro
    Herranz, A.
    Sanjurjo, M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (06) : 479 - 486
  • [7] Dennison Taylor, 2021, J Adv Pract Oncol, V12, P148, DOI 10.6004/jadpro.2021.12.2.3
  • [8] Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center
    Farano, Joelle L.
    Kandah, Huda-Marie
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (07) : 765 - 769
  • [9] Improvement in Safety Monitoring of Biologic Response Modifiers After the Implementation of Clinical Care Guidelines by a Specialty Pharmacy Service in an Academic Health System
    Hanson, Rebekah L.
    Gannon, Michael J.
    Khamo, Nehrin
    Sodhi, Monsheel
    Orr, Alexander M.
    Stubbings, JoAnn
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : 49 - 67
  • [10] Payer site of care mandates with oncology medications: It's time to demand payer accountability on behalf of patients
    Komorny, Kenneth M.
    Burkett, Jason M.
    Mensing, Tracey
    Whaley, Bridget A.
    Robb, Kyle
    Chen, David
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (14) : 939 - 943